By MATTHEW PERRONE

WASHINGTON (AP) — The Food and Drug Administration on Thursday announced the first round of experimental drugs that will receive drastically expedited reviews at the agency, part of an effort to prioritize medicines the Trump administration deems as “supporting U.S. national interests.”

Related Articles

FOX45: Watchdog uncovers Ian Roberts’ MD voter registration application, says it raises red flags

Trump announces a deal with a manufacturer to make a common fertility drug cheaper for IVF patients

California to begin selling affordable state-branded insulin beginning next year

Questions raised on Qatar at Idaho Air Force base

Ex-Trump national security adviser Bolton charged in probe of mishandling of classified information

The nine medicines announced by the

See Full Page